Antiplatelet drug


Also found in: Dictionary, Wikipedia.

Antiplatelet drug

Drug that inhibits platelets from aggregating to form a plug. They are used to prevent clotting and alter the natural course of atherosclerosis.
References in periodicals archive ?
A partial list of current unmet medical needs Selection & Monitoring Efficacy of Antiplatelet Drugs (Personalized or Precision Medicine) Genomic Response Classification (hypo, normo, hyer responder) Monitoring Dual Anti Platelet Therapy Verifying Patient Compliance with Drug Therapy Assessing Residual Platelet Reactivity Risk Assessments (Bleeding, Thrombosis) Activity in Oncology and Infectious Disease Patients Table 3.
The results from the above study thus reflect a need for more specific antiplatelet treatment regimens especially in diabetic subjects, which may include more potent agents or a combination with other antiplatelet drugs.
Impedance aggregometry offers a higher sensitivity for antiplatelet drug effects and platelet hyperactivity than does optical aggregometry (14).
In some cases, adding a second antiplatelet drug to aspirin appeared to provide additional protection.
Addressing every major antiplatelet drug including aspirin, P2Y12 inhibitors (e.
However, there have been few that have specifically reviewed methods of point-of-care assessment of antiplatelet drug effects.
Investigational Oral Antiplatelet Drug, Prasugrel, to European Medicines Agency
Aspirin was the most common antiplatelet drug used; other commonly mentioned drugs included naproxen, piroxicam, and ibuprofen.
McGuire focused on 3,101 patients who had diabetes or were on hypoglycemic therapy and who were enrolled in two trials designed to test the efficacy of an oral antiplatelet drug for patients with acute coronary syndrome.
11 LANCET that the antiplatelet drug abciximab boosts the effectiveness of stents.
SAN DIEGO, May 8, 2015 /PRNewswire/ -- Patients with a high-risk paclitaxel drug-eluting stent who were given the shorter-acting antiplatelet drug cilostazol prior to a surgical procedure safely transitioned off of dual antiplatelet therapy (DAPT) to reduce the risk of bleeding during their operation.
Agonist-activated platelets and fibrinogen-coated polystyrene microparticles agglutinate in whole blood in proportion to the number of available platelet GP lib/Ina receptors, which makes this device appropriate for the measurement of antiplatelet drug (e.